SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Entity Listings [Line Items]
Cash equivalents	$ 0		$ 0		$ 0
Impairment losses on long-lived assets			0
Impairment losses on intangible assets	0	$ 0	0	$ 0
Impairment losses on goodwill	0	0	0	0
Reimbursement of actual costs			40,000
Revenue		$ 1,400,000		$ 1,740,855
In-Vivo [Member]
Entity Listings [Line Items]
Revenue			500,000
Oncotelic, Inc. [Member]
Entity Listings [Line Items]
Due to related parties	$ 500,000		500,000
ATB Agreement [Member] | Japan, China, Brazil, Mexico, Russia and Korea [Member]
Entity Listings [Line Items]
Marketing approval received value			1,000,000
ATB Agreement [Member] | Germany, France, Spain, Italy and UK [Member]
Entity Listings [Line Items]
Marketing approval received value			2,000,000
Golden Mountain Partners LLC [Member] | Research Service Agreement [Member]
Entity Listings [Line Items]
Service fees			300,000
Golden Mountain Partners LLC [Member] | Supplement Research Service Agreement [Member]
Entity Listings [Line Items]
Service fees			900,000
Autotelic BIO [Member] | ATB Agreement [Member]
Entity Listings [Line Items]
Revenue			$ 500,000